Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.

Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.

Item
http://www.wikidata.org/entity/Q46989472
Polyanhydride Nanoparticle Delivery Platform Dramatically Enhances Killing of Filarial WormsSafety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.Nano-enabled delivery of diverse payloads across complex biological barriers.Biomaterials approaches to treating implant-associated osteomyelitis.Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy.Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours.A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis.The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.Pulmonary biodistribution and cellular uptake of intranasally administered monodisperse particles.Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.
P2860

Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.

Item
http://www.wikidata.org/entity/Q46989472
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Evaluation of biocompatibility ...... platform for vaccine delivery.
@en
Evaluation of biocompatibility ...... platform for vaccine delivery.
@nl
type
label
Evaluation of biocompatibility ...... platform for vaccine delivery.
@en
Evaluation of biocompatibility ...... platform for vaccine delivery.
@nl
prefLabel
Evaluation of biocompatibility ...... platform for vaccine delivery.
@en
Evaluation of biocompatibility ...... platform for vaccine delivery.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Evaluation of biocompatibility ...... platform for vaccine delivery.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698